Fundraising Fox

NextPoint Therapeutics

Austin, US · 2 known investors

nextpointtx.com ↗

NextPoint is developing precision cancer therapeutics based on the B7-H7/HHLA2 axis, including T-cell engagers, antibody-drug conjugates, and checkpoint inhibitors for cancer patients. The company focuses on immuno-oncology and tumor-targeting therapies.

BiotechDigital HealthMedical Devices

Investors · 2

MPM BioImpactBoston
Sanofi Ventures

In the news